Wharton Entrepreneurship Conference 2006 - Speakers(Site not responding. Last check: 2007-10-04)
Pete Nicholas is Co-Founder and Chairman of the Board of Boston Scientific Corporation.
Under Pete's vision and leadership, Boston Scientific has grown from a start-up company with 38 employees to a global corporation with approximately 16,000 employees and revenue of $5.5 billion in 2004.
Pete has served on various for-profit and not-for-profit boards, and was formerly Chairman of the Board of Trustees of Duke University.
www.weconference.org /speakers.html (317 words)
The Corporate Library - CEO Contract Study - BSX(Site not responding. Last check: 2007-10-04)
The Board is nominating Pete M. Nicholas and James R. Tobin for re-election and is nominating Ray J. Groves to serve as a new Board member.
Pete Nicholas' children, 170,954 shares of common stock held by Ruth V. Lilly Nicholas and N. Nicholas, Jr.
Pete Nicholas is deemed to have beneficial ownership, and 126,693
Peter Abele: ZoomInfo Business People Information(Site not responding. Last check: 2007-10-04)
Peter Abele's summary was automatically generated using 9 references found on the Internet.
Peter Abele joined AUDI AG in 1986 and occupied several leading positions in the area of Finance and Organisation before he was appointed General Manager with power of attorney in March 1993 and Board Member for this division on 1 June 1997.
Peter Abele was also a member of important committees in the VW Group.Abele, born in Würzburg on 26 June 1941, studied Mechanical Engineering and Industrial Engineering at the Technical University of Aachen from 1963 to 1969.
Writing for the appeals court, Judge PeteAbele acknowledged that plea bargains are legal contracts between the state and criminal defendants, "and are subject to contract law principals."
The court flatly rejected the notion, however, that the prosecutor, and not Adkins, was the party in breach of the contract.
First, the court noted, once it ruled that the trial judge did not fully comply with sentencing guidelines in Ohio law, it became a moot point whether the question of whether the factors considered in sentencing were or were not found by a jury.
In May of 2006, John Abele, the sub commander's son; Art Wright of Williamson and Associates marine engineering; and Kale Garcia of the fishing vessel, Aquila, met in Seattle to discuss plans for a side scanning sonar search in August.
Pete Lowney will handle videography aboard the Aquila and Newman Lanier is the internet specialist.
The search will commence from Dutch Harbor in the first week of August and continue for two to three weeks in the hopes of finding sonar evidence of the Grunion or the other ships believed to have sunk in the area.
Kretschmann said persistence by the sons of the USS Grunion’s commander, Mannert L. Abele, kept the Grunion’s fate from resting forever undiscovered on the ocean floor.
A large underwater mass believed to be the Grunion was found by an expedition led by Bruce, Brad and John Abele, the sons of Mannert L. Abele, commander of the submarine.
Bruce Abele, 76, of Newtonville, Mass., the oldest son, said the group, using side sonar, detected an underwater image that is clearly not a land mass.
Abele believes Wisconsin has an opportunity to capitalize on research emerging from the biotech industry.
In the past year, Abele's name has surfaced as a possible investor in ownership groups that were interested in acquiring the Milwaukee Bucks and Milwaukee Brewers.
Abele said his family has been involved as an investor in the acquisition of the Los Angeles Dodgers.
BioView.com - Corporate Profile - Boston Scientific(Site not responding. Last check: 2007-10-04)
The company's products and technologies are generally used for enlarging narrowed blood vessels to prevent heart attack and stroke, opening passages blocked by tumors or plaque to alleviate pain or suffering, conducting biopsies and ultrasounds, mapping electrical problems in the heart, placing filters to prevent blood clots from reaching the lungs, and treating brain aneurysms.
Boston Scientifics' history began in the late 1960s, when co-founder John Abele acquired an equity interest in Medi-tech, Inc., and a development company focused on developing alternatives to surgery.
In 1979, Abele joined Pete Nicholas to form Boston Scientific for the purpose of acquiring Medi-tech.
Synactive Software | Customers | Boston Scientific Symbiosis(Site not responding. Last check: 2007-10-04)
The Company's products and technologies are used for preventing heart attack and stroke, bringing relief to cancer patients, mapping electrical problems in the heart, preventing blood clots in the lungs and treating urological, renal, cerebrovascular and gastrointestinal diseases.
The Company's history began in the late 1960s, when co-founder John Abele acquired an equity interest in Medi-tech, an R&D company focused on developing alternatives to traditional surgery.
In 1979, Abele and Pete Nicholas partnered to buy Medi-tech and together formed Boston Scientific.
Although the leg on the table has some hint of a traditional cabriole design (my initial observation), she felt it was quite indicative of an animal's limb--and felt "alive".
But now that Pete brings it up...the resemblance to a whale's tail when you look at the object as a whole is is striking.
All traditional furniture legs were inspired by animals throughout tme...Your observation is correct and interesting.
MDIS: Boston Scientific Ltd(Site not responding. Last check: 2007-10-04)
Get a sense of the unique environment and culture that is Boston Scientific, a community of people who strive to help physicians save lives and improve the quality of life for patients.
In 1979, Abele and Pete Nicholas partnered to buy Medi-tech and together formed Boston Scientific Corporation.
Driven by the needs of the medical community for innovative products, the Company grew from revenues of approximately $2 million in 1979 to more than $2.6 billion in 2000.
Boston Scientific's history began in the late 1960s when the Company's co-founder, John Abele, acquired an equity interest in Medi-tech, Inc., a development company.
They were used in some of the first less-invasive procedures performed, and versions of these catheters are still being sold today.
In 1979, John Abele joined Pete Nicholas to form Boston Scientific Corporation for the purpose of acquiring Medi-tech, Inc. The acquisition began a period of active, focused marketing, new product development, and organizational growth.
In most cases, you will find several short video lessons from each leader relevant to a range of different business issues.
John Abele is the industry leader whose foresight has earned him a well-deserved reputation as a pioneer in less invasive medicine.
Sanjiv Ahuja, the man who led IBM’s entry into the telecommunications software industry, is both a strong leader and at the forefront of cutting-edge technology in a rapidly changing sector.
Add yourself to the largest index of business people in the world.
John Abele's summary was automatically generated using 1 reference found on the Internet.
Boston Scientific's history began in the late 1960s, when co-founder John Abele acquired an equity interest in Medi-tech, Inc., a research and development company focused on developing alternatives to traditional surgery.
She was also preceded in death by a daughter, Nancy Smith Maiden, who died in December 1987, and a brother, Pete, who died in 1950.
He was a member of the Hocking Hills Country Club, executive and finance chairman of Hocking County Republicans Club and field representative for U.S. Congressman PeteAbele from 1962 to 1964.
Also surviving are two sons, William (Darlene) Blosser of Delray Beach, Fla., and Charles (Valerie) Blosser of Reynoldsburg; five grandchildren, Kevin Blosser of Pickerington, Kelly Blosser Kerr of Gahanna, Tina Blosser and Todd Blosser of Melbourne, Fla., and Renee Blosser of Delray Beach; four stepgrandchildren and five great-grandchildren.
3-DNET® Company Profiles(Site not responding. Last check: 2007-10-04)
While still under the name of Medi-tech, the company introduced its first products in 1969, a line of steerable catheters, versions of which are still used today.
In 1979, John Abele and Pete Nicholas partnered up to buy Medi-tech and transform it into a large-scale corporation.
Boston Scientific went public in 1992 and undertook an aggressive acquisition strategy, growing from approximately $2 million in 1979 to more than $2.67 billion in 2001.
The company pursues this mission through continuing refinement and development of products and technologies that can reduce risk, trauma, cost, procedure time, and the need for aftercare.
Boston Scientific’s history began in the late 1960’s, when co-founder John Abele acquired an equity interest in Medi-tech, Inc., a small research and design company focused on developing alternatives to traditional surgery.
Driven by the needs of the medical community for innovation and breakthrough products, the company grew from revenues of approximately $2 million in 1979 to more than $3 billion in 2000.
The company's headquarters are in Natick with 26 manufacturing and distribution centers worldwide.
Boston Scientific began in the late 1960s, when co-founder John Abele acquired an equity interest in Medi-tech, Inc., a research and development company focused on developing alternatives to traditional surgery.
Athens County Democratic Party, C. David Warren, Prosecuting Attorney(Site not responding. Last check: 2007-10-04)
While serving as Assistant County Prosecutor Dave had the honor of serving from time to time as Village Solicitor and occasionally Special Prosecutor for each Village in Athens County as well as Morgan and Vinton Counties.
In 1991 Dave was chosen by Judge Roger Jones to serve as the Magistrate of Athens County Juvenile Court to fill the vacancy created by the election of Judge PeteAbele to the Fourth District Court of Appeals.
Later in 1991 Judge William Lavelle appointed Dave as Magistrate.